Lijuan Jiang

590 total citations
38 papers, 373 citations indexed

About

Lijuan Jiang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lijuan Jiang has authored 38 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lijuan Jiang's work include Bladder and Urothelial Cancer Treatments (11 papers), RNA modifications and cancer (7 papers) and Renal cell carcinoma treatment (6 papers). Lijuan Jiang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), RNA modifications and cancer (7 papers) and Renal cell carcinoma treatment (6 papers). Lijuan Jiang collaborates with scholars based in China, Australia and France. Lijuan Jiang's co-authors include Fangjian Zhou, Zhiling Zhang, Hailong Wang, Yangbo Chen, Yonghong Li, Zhuowei Liu, Chunping Yu, Dan Xie, Wensu Wei and Minhua Deng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Lijuan Jiang

36 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijuan Jiang China 12 200 105 98 78 54 38 373
Daniele Spada Italy 10 99 0.5× 57 0.5× 19 0.2× 57 0.7× 36 0.7× 23 275
Yun Qiao China 10 154 0.8× 115 1.1× 47 0.5× 86 1.1× 8 0.1× 29 405
Zhijie Yin China 10 222 1.1× 111 1.1× 38 0.4× 177 2.3× 12 0.2× 22 377
Concetta Di Mauro Italy 11 327 1.6× 83 0.8× 17 0.2× 61 0.8× 36 0.7× 21 476
Hongke Cai China 12 193 1.0× 59 0.6× 125 1.3× 138 1.8× 129 2.4× 43 560
John D. Karalis United States 11 117 0.6× 113 1.1× 73 0.7× 89 1.1× 58 1.1× 31 467
Hye-Lim Lee South Korea 12 213 1.1× 73 0.7× 41 0.4× 70 0.9× 4 0.1× 13 475
Wenting Yan China 13 291 1.5× 62 0.6× 49 0.5× 244 3.1× 31 0.6× 28 613
Linna Ge United States 13 156 0.8× 119 1.1× 24 0.2× 68 0.9× 28 0.5× 19 417

Countries citing papers authored by Lijuan Jiang

Since Specialization
Citations

This map shows the geographic impact of Lijuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Jiang more than expected).

Fields of papers citing papers by Lijuan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Jiang. The network helps show where Lijuan Jiang may publish in the future.

Co-authorship network of co-authors of Lijuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Jiang. A scholar is included among the top collaborators of Lijuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Jiang. Lijuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wentao, Xin‐zhuan Su, Yuying Pan, et al.. (2025). Chlamydial protease-like activity factor targets SLC7A11 for degradation to induce ferroptosis and facilitate progeny releases. PLoS Pathogens. 21(4). e1013060–e1013060. 1 indexed citations
2.
Li, Xiaorui, Biao Feng, Lei Gao, et al.. (2025). Tensile-Strain-Promoted In Situ Electrochemical Hydrogen Intercalation Stabilizes Pd Icosahedra toward Oxygen Reduction. Nano Letters. 25(49). 17104–17111.
3.
4.
Jiang, Lijuan, et al.. (2023). PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Pathology - Research and Practice. 247. 154536–154536. 14 indexed citations
6.
Deng, Minhua, Ning Wang, Zhiyong Li, et al.. (2022). FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA. Cell Death and Disease. 13(2). 170–170. 18 indexed citations
7.
Zhou, Zhaohui, Lijuan Jiang, Yonghong Li, et al.. (2022). Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1. Cell Death and Disease. 13(5). 492–492. 3 indexed citations
8.
Li, Yonghong, Ning Wang, Jun Wang, et al.. (2022). Cytoreductive prostate cryoablation and metronomic cyclophosphamide for metastatic hormone-sensitive prostate cancer. Future Oncology. 18(19). 2373–2380. 2 indexed citations
9.
Wei, Wensu, Ning Wang, Minhua Deng, et al.. (2021). LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis. Redox Biology. 48. 102201–102201. 33 indexed citations
10.
Jiang, Lijuan, Yanjun Wang, Xiangdong Li, et al.. (2021). CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer. Frontiers in Genetics. 12. 663982–663982. 5 indexed citations
11.
Li, Zhiyong, Zhiling Zhang, Kai Yao, et al.. (2021). Extraperitonealization of ileal conduit reduces parastomal hernia after cystectomy and ileal conduit diversion. Urologic Oncology Seminars and Original Investigations. 40(4). 162.e17–162.e23. 5 indexed citations
12.
Zhang, Yingqiang, Lijuan Jiang, Yinfeng Xu, et al.. (2019). Gefitinib with or without Transarterial Infusion Chemotherapy (Cisplatin) for Large Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations. Journal of Vascular and Interventional Radiology. 30(7). 1004–1012. 8 indexed citations
13.
Yu, Chunping, Zhuowei Liu, Qiuhong Chen, et al.. (2018). Nkx2.8 Inhibits Epithelial–Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Twist1. Cancer Research. 78(5). 1241–1252. 13 indexed citations
14.
Chen, Xin, Zhuowei Liu, Wensu Wei, et al.. (2018). Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 115–115. 16 indexed citations
15.
Zhang, Yingqiang, Lijuan Jiang, Guihua Huang, et al.. (2018). Comparison of α-Fetoprotein Criteria and Modified Response Evaluation Criteria in Solid Tumors for the Prediction of Overall Survival of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology. 29(12). 1654–1661. 15 indexed citations
16.
Jiang, Lijuan, et al.. (2017). Influencing factor analysis of the number of lymph nodes harvest after radical resection of colorectal cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 16(7). 731–735. 1 indexed citations
17.
Zhang, Zhiling, et al.. (2016). The Difference in Prognosis between Renal Sinus Fat and Perinephric Fat Invasion for pT3a Renal Cell Carcinoma: A Meta-Analysis. PLoS ONE. 11(2). e0149420–e0149420. 32 indexed citations
18.
Wu, Zhiming, Huan Huang, Zhuowei Liu, et al.. (2014). [Activation of p21(WAF1/CIP1) by small activating RNA inhibits cell proliferation and induces apoptosis in BEL-7402 hepatoma cell].. PubMed. 94(20). 1534–8. 1 indexed citations
19.
Li, Yonghong, Yiji Liao, Shi‐Juan Mai, et al.. (2013). High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical Cystectomy. BioMed Research International. 2013. 1–8. 18 indexed citations
20.
Dong, Pei, Lijuan Jiang, Jianye Liu, et al.. (2013). Induction of Paclitaxel Resistance by ERα Mediated Prohibitin Mitochondrial-Nuclear Shuttling. PLoS ONE. 8(12). e83519–e83519. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026